Literature DB >> 2180285

Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome.

M Godfrey1, S Olson, R G Burgio, A Martini, M Valli, G Cetta, H Hori, D W Hollister.   

Abstract

The Marfan syndrome is a dominantly inherited connective-tissue disorder characterized by ocular, cardiovascular, and musculoskeletal abnormalities. Although the underlying biochemical and molecular defect(s) of this pleiotropic disease is currently unknown, we have consistently observed apparent diminished content of elastin-associated microfibrillar fibers accumulating in skin, or produced by cultured fibroblasts, from patients with the Marfan syndrome and have documented the cosegregation of these immunofluorescent abnormalities of microfibrillar fibers with the Marfan syndrome phenotype in family studies. Recently, an unusual patient has been described with unilateral phenotypic features of the Marfan syndrome, providing an unique opportunity to compare microfibrillar fibers and other connective-tissue components between the affected and nonaffected sides. In the present report, we demonstrate striking differences in apparent content of microfibrillar fibers, as determined by indirect immunofluorescence of skin and fibroblast cultures, that are revealed when multiple homologous samples derived from different sides of the patient's body are compared. In contrast, no differences in apparent content of type III collagen or in the biosynthesis and apparent structure of types I and III (pro)collagens were found. HLA types and chromosome heteromorphisms were identical in fibroblasts from both sides of the body, eliminating the formal possibility of chimerism and suggesting that a postzygotic mutation accounts for the asymmetric manifestation of the Marfan syndrome in this patient. The observation of striking decreases in microfibrillar fibers on the affected side of the body provides further evidence that abnormalities of this component of the elastic fiber system may be central to the pathogenesis and possibly the etiology of the Marfan syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180285      PMCID: PMC1683667     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  The major antigen of elastin-associated microfibrils is a 31-kDa glycoprotein.

Authors:  M A Gibson; J L Hughes; J C Fanning; E G Cleary
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

2.  Characterization of a structural glycoprotein from bovine ligamentum nuchae exhibiting dual amine oxidase activity.

Authors:  A Serafini-Fracassini; G Ventrella; M J Field; J Hinnie; N I Onyezili; R Griffiths
Journal:  Biochemistry       Date:  1981-09-15       Impact factor: 3.162

Review 3.  Elastin-associated microfibrils and microfibrillar proteins.

Authors:  E G Cleary; M A Gibson
Journal:  Int Rev Connect Tissue Res       Date:  1983

4.  Marfan's syndrome: structural, biochemical, and mechanical studies of the aortic media.

Authors:  A J Perejda; P A Abraham; W H Carnes; W F Coulson; J Uitto
Journal:  J Lab Clin Med       Date:  1985-10

Review 5.  The eye in the Marfan syndrome.

Authors:  I H Maumenee
Journal:  Trans Am Ophthalmol Soc       Date:  1981

6.  The protein composition of the ocular zonules.

Authors:  B W Streeten; D A Swann; P A Licari; M R Robinson; S A Gibson; N J Marsh; J P Vergnes; I L Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-01       Impact factor: 4.799

7.  Human chromosome variation: the discriminatory power of Q-band heteromorphism (variant) analysis in distinguishing between individuals, with specific application to cases of questionable paternity.

Authors:  S B Olson; R E Magenis; E W Lovrien
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

Review 8.  Elastin: relation of protein and gene structure to disease.

Authors:  J Rosenbloom
Journal:  Lab Invest       Date:  1984-12       Impact factor: 5.662

9.  Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.

Authors:  G S Barsh; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.

Authors:  L Y Sakai; D R Keene; E Engvall
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  13 in total

1.  Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.

Authors:  D M Milewicz; R E Pyeritz; E S Crawford; P H Byers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene.

Authors:  K Kainulainen; B Steinmann; F Collins; H C Dietz; C A Francomano; A Child; M W Kilpatrick; D J Brock; M Keston; R E Pyeritz
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

3.  A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling.

Authors:  Helena Karlström; Paul Beatus; Karin Dannaeus; Gavin Chapman; Urban Lendahl; Johan Lundkvist
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  Marfan syndrome: light at the end of the tunnel?

Authors:  P Tsipouras
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

5.  Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts.

Authors:  E A Putnam; E S Park; C M Aalfs; R C Hennekam; D M Milewicz
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation.

Authors:  T Rantamäki; I Kaitila; A C Syvänen; M Lukka; L Peltonen
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 7.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

Review 8.  Dysmorphic disorders--an overview.

Authors:  D Donnai
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 9.  Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.

Authors:  D M Milewicz
Journal:  Tex Heart Inst J       Date:  1994

10.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.